The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A study on the association between infectious burden and Alzheimer's disease
Abstract
Background and purpose: Previous studies suggested that the overall burden of prior infections contributes to cardiovascular diseases and stroke. In the present study, the association between infectious burden (IB) and Alzheimer's disease (AD) was examined. Methods: Antibody titers to common infectious pathogens including cytomegalovirus (CMV), herpes simplex virus type 1 (HSV‐1), B orrelia burgdorferi, C hlamydophila pneumoniae and H elicobacter pylori were measured by enzyme‐linked immunosorbent assay in 128 AD patients and 135 healthy controls. IB was defined as a composite serological measure of exposure to these common pathogens. Results: Seropositivities toward zero−two, three and four−five of these pathogens were found in 44%, 40% and 16% of healthy controls but in 20%, 44% and 36% of AD patients, respectively. IB, bacterial burden and viral burden were independently associated with AD after adjusting for age, gender, education, APOE genotype and various comorbidities. Mini‐Mental State Examination scores were negatively correlated with IB in all cases. Serum beta‐amyloid protein (A β) levels (i.e. A β40, A β42 and total A β) and inflammatory cytokines (i.e. interferon‐γ, tumor necrosis factor α, interleukin‐1β and interleukin‐6) in individuals exposed to four−five infectious pathogens were significantly higher than those exposed to zero−two or three pathogens. Conclusions: IB consisting of CMV, HSV‐1, B. burgdorferi, C. pneumoniae and H. pylori is associated with AD. This study supports the role of infection/inflammation in the etiopathogenesis of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease
Itzhaki, R. F., Lin, W.-R., Shang, D., Wilcock, G. K., Faragher, B., & Jamieson, G. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10149-5 · Cited by 669
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain
Balin, B. J., Gérard, H. C., Arking, E. J., Appelt, D. M., Branigan, P. J., Abrams, J. T., Whittum-Hudson, J. A., & Hudson, A. P. (1998) · Medical Microbiology and Immunology · doi:10.1007/s004300050071 · Cited by 506
Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J., Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., & Zhou, H. D. (2011) · Neurology · doi:10.1212/wnl.0b013e318217e7a4 · Cited by 367
Self-citationRiviere, G. R., Riviere, K. H., & Smith, K. S. (2002) · Oral Microbiology and Immunology · doi:10.1046/j.0902-0055.2001.00100.x · Cited by 362
Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation
Wozniak, M. A., Itzhaki, R. F., Shipley, S. J., & Dobson, C. B. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.077 · Cited by 341
Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis
Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., Bickel, C., Kopp, H., Rippin, G., Victor, A., Hafner, G., Schlumberger, W., & Meyer, J. (2002) · Circulation · doi:10.1161/hc0102.101362 · Cited by 338
Inflammatory factors are elevated in brain microvessels in Alzheimer's disease
Grammas, P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00276-7 · Cited by 291
Genetics of familial and sporadic Alzheimer s disease
Piaceri, I. (2013) · Frontiers in Bioscience · doi:10.2741/e605 · Cited by 256
Rupprecht, H. J., Blankenberg, S., Bickel, C., Rippin, G., Hafner, G., Prellwitz, W., Schlumberger, W., & Meyer, J. (2001) · Circulation · doi:10.1161/hc2601.091703 · Cited by 253
Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice
Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J., & Appelt, D. M. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00127-1 · Cited by 243
Leisure activity and risk of cognitive impairment: The Chongqing aging study
Wang, J. Y. J., Zhou, D. H. D., Li, J., Zhang, M., Deng, J., Tang, M., Gao, C., Li, J., Lian, Y., & Chen, M. (2006) · Neurology · doi:10.1212/01.wnl.0000192165.99963.2a · Cited by 204
Self-citationEmerging roles of pathogens in Alzheimer disease
Miklossy, J. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002006 · Cited by 201
Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes
MIKLOSSY, J., KIS, A., RADENOVIC, A., MILLER, L., FORRO, L., MARTINS, R., REISS, K., DARBINIAN, N., DAREKAR, P., & MIHALY, L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.018 · Cited by 189
Infiltration of the brain by pathogens causes Alzheimer’s disease
Itzhaki, R. F., Wozniak, M. A., Appelt, D. M., & Balin, B. J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.021 · Cited by 188
Infectious Burden and Risk of Stroke: The Northern Manhattan Study
Elkind, M. S. V. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.271 · Cited by 177
Can Infections Cause Alzheimer's Disease?
Mawanda, F., & Wallace, R. B. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs007 · Cited by 166
Infectious burden and cognitive function: The Northern Manhattan Study
Katan, M., Moon, Y. P., Paik, M. C., Sacco, R. L., Wright, C. B., & Elkind, M. S. V. (2013) · Neurology · doi:10.1212/wnl.0b013e3182896e79 · Cited by 141
Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice
McManus, R. M., Higgins, S. C., Mills, K. H. G., & Lynch, M. A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.025 · Cited by 139
Alzheimerʼs disease—a spirochetosis?
Miklossy, J. (1993) · Neuroreport · doi:10.1097/00001756-199307000-00002 · Cited by 136
Strandberg, T. E., Pitkälä, K. H., Linnavuori, K. H., & Tilvis, R. S. (2003) · Stroke · doi:10.1161/01.str.0000086754.32238.da · Cited by 133
Alzheimer Disease -- A Spirochetosis?
Judith Miklossy, A. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_7 · Cited by 130
(2012) · doi:10.1038/nrneurol.2012.118 · Cited by 122
Self-citationConcurrent neocortical borreliosis and Alzheimer's disease
MacDonald, A. B., & Miranda, J. M. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80252-6 · Cited by 112
Helicobacter pylori and Alzheimer's disease: a possible link
Malaguarnera, M., Bella, R., Alagona, G., Ferri, R., Carnemolla, A., & Pennisi, G. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.05.008 · Cited by 112
Past exposure to vaccines and subsequent risk of Alzheimer's disease.
Verreault, R., Laurin, D., Lindsay, J., & Serres, G. D. (2001) · Europe PMC (PubMed Central) · Cited by 111
A Brief History of Alzheimer's Disease Gene Discovery
Tanzi, R. E. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129044 · Cited by 82
Carter, C. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/501862 · Cited by 72
Infection and Alzheimer's Disease: The APOE ε4 Connection and Lipid Metabolism
Urosevic, N., & Martins, R. N. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13407 · Cited by 69
Nagele, R. G., Clifford, P. M., Siu, G., Levin, E. C., Acharya, N. K., Han, M. C., Kosciuk, M. C., Venkataraman, V., Zavareh, S., Zarrabi, S., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110098 · Cited by 68
Inflammation in Alzheimer’s disease: insights from immunotherapy
Schott, J. M., & Révész, T. (2013) · Brain · doi:10.1093/brain/awt231 · Cited by 51
Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies
Liu, Y.-H., Zeng, F., Wang, Y., Zhou, H., Giunta, B. N., Tan, J., & Wang, Y. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.020 · Cited by 49
Self-citationMagierski, R., Kłoszewska, I., & Sobów, T. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60005-0 · Cited by 28
Cytomegalovirus infection and Alzheimer’s disease
RENVOIZE, E. B., & HAMBLING, M. H. (1984) · Age and Ageing · doi:10.1093/ageing/13.4.205 · Cited by 27
Zeng, F., Zou, H., Zhou, H., Li, J., Wang, L., Cao, H.-Y., Yi, X., Wang, X., Liang, C., Wang, Y., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.061 · Cited by 23
Self-citation
Cited by
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Interactions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0116-6 · Cited by 965
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
Zhuang, Z.-Q., Shen, L.-L., Li, W.-W., Fu, X., Zeng, F., Gui, L., Lü, Y., Cai, M., Zhu, C., Tan, Y.-L., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180176 · Cited by 885
Self-citation
Metadata
- Authors
- Bu, X. ‐., Yao, X. ‐., Jiao, S. ‐., Zeng, F., Liu, Y. ‐., Xiang, Y., Liang, C. ‐., Wang, Q. ‐., Wang, X., Cao, H. ‐., Yi, X., Deng, B., Liu, C. ‐., Xu, J., Zhang, L. ‐., Gao, C. ‐., Xu, Z. ‐., Zhang, M., Wang, L., Tan, X. ‐., Xu, X., Zhou, H. ‐., & Wang, Y. ‐.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2014-06-09
- Volume
- 22
- Issue
- 12
- Pages
- 1519-1525
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W1976936948
- Cited by
- 273
- References
- 36
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.